Gene · 389
Papers2,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deconvolution of the hematopoietic stem cell microenvironment reveals a high degree of specialization and conservation. | iScience | 2022 | 35494238 | PubTator, text mining | PubMed |
| Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis. | Cancer Commun (Lond) | 2022 | 35470988 | PubTator, text mining | PubMed |
| Identification of Potential Key Genes in Prostate Cancer with Gene Expression, Pivotal Pathways and Regulatory Networks Analysis Using Integrated Bioinformatics Methods. | Genes (Basel) | 2022 | 35456461 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs. | Biomolecules | 2022 | 35454102 | PubTator, text mining | PubMed |
| New Insights into the Roles of lncRNAs as Modulators of Cytoskeleton Architecture and Their Implications in Cellular Homeostasis and in Tumorigenesis. | Noncoding RNA | 2022 | 35447891 | PubTator, text mining | PubMed |
| SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma. | J Exp Clin Cancer Res | 2022 | 35440004 | PubTator, text mining | PubMed |
| Long noncoding RNA LINC00857 promotes pancreatic cancer proliferation and metastasis by regulating the miR-130b/RHOA axis. | Cell Death Discov | 2022 | 35418193 | PubTator, text mining | PubMed |
| Significant reduction of long non-coding RNAs expression in bipolar disorder. | BMC Psychiatry | 2022 | 35410190 | PubTator, text mining | PubMed |
| Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer. | Cancers (Basel) | 2022 | 35406455 | PubTator, text mining | PubMed |
| Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype. | ChemMedChem | 2022 | 35403825 | PubTator, text mining | PubMed |
| YAP Transcriptional Activity Dictates Cell Response to TNF In Vitro. | Front Immunol | 2022 | 35401557 | PubTator, text mining | PubMed |
| Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. | Nat Rev Cancer | 2022 | 35393541 | PubTator, text mining | PubMed |
| Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. | Front Oncol | 2022 | 35392236 | PubTator, text mining | PubMed |
| Cell Trafficking at the Intersection of the Tumor-Immune Compartments. | Annu Rev Biomed Eng | 2022 | 35385679 | PubTator, text mining | PubMed |
| Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis. | Exp Mol Med | 2022 | 35379935 | PubTator, text mining | PubMed |
| A Role of Caveolae in Trabecular Meshwork Mechanosensing and Contractile Tone. | Front Cell Dev Biol | 2022 | 35372369 | PubTator, text mining | PubMed |
| The Small GTPase RHOA Links SLP65 Activation to PTEN Function in Pre B Cells and Is Essential for the Generation and Survival of Normal and Malignant B Cells. | Front Immunol | 2022 | 35371049 | PubTator, text mining | PubMed |
| Fusion of Majorana bound states with mini-gate control in two-dimensional systems. | Nat Commun | 2022 | 35365644 | PubTator, text mining | PubMed |
| Mechanical stress shapes the cancer cell response to neddylation inhibition. | J Exp Clin Cancer Res | 2022 | 35354476 | PubTator, text mining | PubMed |
| The Oncogenic Effects, Pathways, and Target Molecules of JC Polyoma Virus T Antigen in Cancer Cells. | Front Oncol | 2022 | 35350574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389/papers?page=20